Lipid profile in gallstone disease: new perspectives
Abstract
The purpose of the review. Analyze basic data on the contribution of serum lipids blood in the development of gallstone disease (GSD), how in the world, and on Northern Russia, as well as new therapeutic strategies in the treatment of GSD. Recent literature data prevalence of the GSD in the world is 10–15 %. According to some epidemiological and clinical studies, serum lipid profile did not differ in patients with and without GSD, in others – the GSD was accompanied by hyperlipidemia. In epidemiological study among the unorganized population of Novosibirsk GSD found significantly more frequently among men and women with lipid metabolism disorders. Among Asian Indigenous Peoples of the Russian North (with a less severe hyperlipidemia) GSD met less frequently than among aliens. In addition to biliary way of cholesterol catabolism recently discovered transintestinal cholesterol efflux (TICE) in the proximal small intestine. The impact on this mechanism, in particular with the use of ezetimibe, is considered as a promising approach in the treatment of not only atherosclerosis, but and GSD.
About the Authors
I. N. Grigorieva
RAMS
Russian Federation
Russian Federation
SB RAMS
Institution of the Russian Academy of Medical Sciences Research Institute of Therapy
630089
st. B. Bogatkova, 175/1
Novosibirsk
L. V. Scherbakova
RAMS
Russian Federation
Russian Federation
SB RAMS
Institution of the Russian Academy of Medical Sciences Research Institute of Therapy
630089
st. B. Bogatkova, 175/1
Novosibirsk
References
1. Григорьева И. Н. Липидный обмен и желчно-каменная болезнь / И. Н. Григорьева, Ю. П. Никитин. – Новосибирск, 2005. – 176 с.
2. Yoo E.-H., Lee S.-Y. The prevalence and risk factors for gallstone disease // Clin. Chem. Lab. Med. 2009. Vol. 47 (7). P. 795–807.
3. Максимов В. А. Распространенность холелитиаза по данным ультразвукового исследования желчевыделительной системы / В. А. Максимов [и др.] // Практикующий врач. – 1998. – № 13. – С. 27–28.
4. Ruhl C. E., Everhart J. E. Gallstone Disease Is Associated With Increased Mortality in the United States // Gast roenterology. 2010. Nov. 11. [Epub ahead of print].
5. Smelt A. H. Triglycerides and gallstone formation // Clin. Chim. Acta. 2010. Vol. 411 (21-22). P. 1625–1631.
6. Venneman N. G., van Erpecum K. J. Pathogenesis of gallstones // Gastroenterol. Clin. North Am. 2010. Vol. 39 (2). P. 171–183.
7. Barbara L., Sama C., Morselli Labate A. M. et al. A population study on the prevalence of gallstone disease: the Sirmione Study // Hepatology. 1987. Vol. 7 (5). P. 913–917.
8. Saraya A., Irshad M., Gandhi B. M. et al. Plasma lipid profile in gallstone patients from North India // Trop. Gastroenterol. 1995. Vol. 16 (4). P. 16–21.
9. Mellstrom D., Asztely M., Svanik J. Gallstones and previous cholecystectomy in 77- to 78-year-old women in an urban population in Sweden // Scand. J. Gastroenterol. 1988. Vol. 23. P. 1241–1243.
10. Diehl A. K. Epidemiology and Natural History of Gallstone Disease // Gastroenterol. Clin. North Am. 1991. Vol. 20 (1). P. 1–19.
11. Raison J., Bonithon-Kopp C., Egloff M. et al. Hormonal influences on the relationship between body fatness, body fat distribution, lipids, lipoproteins, glucose and blood pressure in French working women // Atherosclerosis. 1990. Vol. 85 (2). P. 185–192.
12. Tsai C. J., Leitzmann M. F., Willett W. C., Giovannucci E. L. Macronutrients and insulin resistance in cholesterol gallstone disease // Am. J. Gastroenterol. 2008. Vol. 103 (11). P. 2932–2932.
13. Pettiti D. B., Friedman G. D., Klatsky A. L. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol // New Engl. J. Med. 1981. Vol. 23. P. 1396–1398.
14. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease (GREPCO) // Hepatology. 1988. Vol. 8. P. 907–913.
15. Петухов В. А. Желчно-каменная болезнь и беременность: причинно- следственные взаимосвязи / В. А. Петухов, М. Р. Кузнецов, С. В. Лисин // Анналы хирургии. – 1998. – № 2. – С. 14–21.
16. Лузина Е. В. Патогенетическая роль нарушений обмена липидов и их пероксидации при заболеваниях желчевыводящих путей у жителей Забайкалья : Авт. дис. ... канд. мед. наук / Е. В. Лузина. – Иркутск, 2000. – 24 с.
17. Мансуров Х. Х. О роли липопротеидов и триглицеридов в холестериновом литогенезе / Х. Х. Мансуров [и др.] // Клин. медицина. – 1994. – № 5. – С. 31–33.
18. Uhler M., Marks J., Judd H. L. Estrogen replacement therapy and gallbladder disease in postmenopausal women // Menopause. 2000. Vol. 7 (3). P. 162–167.
19. Amigo L., Quiñones V., Leiva A. еt al. Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice // Liver Int. 2011. Vol. 31 (2). P. 263–271.
20. Attili A. F., Carulli N., Roda E. et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) // Am. J. Epidemiol. 1995. Vol. 141 (2). P. 158–165.
21. Braghetto I., Antezana C., Hurtado C. et al. Trig lyceride and Cholesterol Content in Bile, Blood, and Gallbladder Wall // Am. J. Surg. 1988. Vol. 156. P. 26–28.
22. Войнова Л. В. Особенности обмена липидов крови и желчи у больных желчно-каменной болезнью / Л. В. Войнова // РЖГГК. – 2004. – № 5 (Прил. 23). – С. 96.
23. Attili A. F., De Santis A., Capri R. et al. The natural history of Gallstones: the GREPCO Experience // Hepatology. 1995. Vol. 21 (3). P. 656–660.
24. Duque M. X., Moron S., Salmerуn Castro J. et al. Inverse association between plasma cholesterol and gallstone disease // Arch. Med. Res. 1999. Vol. 30 (3). P. 190–197.
25. Thijs C., Knupschild P., Brombaher P. Serum lipids and gallstones: a case–control study // Gastroenterology. 1990. Vol. 99 (3). P. 843–849.
26. Панин Л. Е. Рациональное питание на Севере – основа первичной профилактики / Л. Е. Панин // Проблемы современного социального развития народностей Севера. – Новосибирск, 1987. – С. 223–230.
27. Цуканов В. В. Механизм обратного транспорта холестерина и холелитиаз у северных народностей / В. В. Цуканов [и др.] // Клин. медицина. – 2007. – Т. 85, № 2. – С. 33–35.
28. Цуканов В. В. Метаболические факторы защиты коренного населения Севера при ИБС и холелитиазе / В. В. Цуканов [и др.] // Бюл. СО РАМН. – 2006. – № 2. – С. 100–104.
29. Райков А. Н. Липиды крови как фактор реализации наследственной предрасположенности к ИБС / А. Н. Райков, Э. Ш. Халфен // Кардиология. – 1989. – № 6. – С. 14–19.
30. Селевич М. И. Некоторые показатели липидного обмена в плазме крови больных хроническим калькулезным холециститом / М. И. Селевич [и др.] // Терапевт. архив. – 1998. – № 2. – С. 46–48.
31. van der Velde A. E., Brufau G., Groen A. K. Transintestinal cholesterol efflux // Curr. Opin. Lipidol. 2010. Vol. 21 (3). P. 167–171.
32. Katsika D., Magnusson P., Krawczyk M. еt аl. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype // J. Intern. Med. 2010. Vol. 268 (3). P. 279–285.
33. Vrins C. L. The Netherlands. From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux // World. J. Gastroenterol. 2010. Vol. 16 (47). P. 5953–5957.
34. Vrins C. L., van der Velde A. E., van den Oever K. еt аl. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux // J. Lipid. Res. 2009. Vol. 50 (10). P. 2046–2054.
35. van der Veen J. N., Kruit J. K., Havinga R. еt аl. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1 // J. Lipid. Res. 2005. Vol. 46 (3). P. 526–534.
36. van der Veen J. N., van Dijk T. H., Vrins C. L. еt аl. Activation of the liver X receptor stimulates transintestinal excretion of plasma cholesterol // J Biol. Chem. 2009. Vol. 284 (29). P. 19211–19219.
37. Portincasa P., Di Ciaula A., Wang H. H. еt аl. Medicinal treatments of cholesterol gallstones: old, current and new perspectives // Curr. Med. Chem. 2009. Vol. 16 (12). P. 1531–1542.
38. Vidyashankar S., Sambaiah K., Srinivasan K. Regression of preestablished cholesterol gallstones by dietary garlic and onion in experimental mice // Metabolism. 2010. Vol. 59 (10). P. 1402–1412.
39. Tsai C. J., Leitzmann M. F., Willett W. C., Giovannucci E. L. Statin use and the risk of cholecystectomy in women // Gastroenterology. 2009. Vol. 136 (5). P. 1593–1600.
40. Bodmer M., Brauchli Y. B., Krähenbühl S. еt аl. Statin use and risk of gallstone disease followed by cholecystectomy // JAMA. 2009. Vol. 302 (18). P. 2001–2007.
Review
For citations:
Grigorieva I.N., Scherbakova L.V. Lipid profile in gallstone disease: new perspectives. Ateroscleroz. 2011;7(1):70-75. (In Russ.)
Views:
190
Email this article 